Pharmaceutical Care for an Elderly Patient with Pulmonary Bacterial and Fungal Infection

Abstract

Abstract: Objective To investigate the model of pharmaceutical care for elderly patients with pulmonary bacterial and fungal infection. Methods Through participating in the medication of one case of elderly patient with pulmonary bacterial and fungal infection, clinical pharmacist discussed the medication regimen with physicians, put forward effective suggestions for clinical medication scheme and provided reasonable pharmaceutical care. Results The effective pharmaceutical care improved the patient's therapeutic efficacy, individuated the clinical medication scheme. At last, this patient was cured. Conclusion Clinical pharmacists should take their advantages to contribute to clinical therapy, optimize the medication regimen from the medicine choice, interactions, adverse reactions and so on.

Key words: bacterial infection, fungal infection, elderly patient, pneumonia

CLC Number:

R969.3

SUN Hong-shuang,NIE Chun-cheng,MA Hong-fang,CHEN He-jun,ZHONG Bao-gui. Pharmaceutical Care for an Elderly Patient with Pulmonary Bacterial and Fungal Infection[J]. Chinese Journal of Pharmacovigilance, 2015, 12(3): 182-183.

Add to citation manager EndNote|Ris|BibTeX

URL: https://zgywjj.magtechjournal.com/EN/

https://zgywjj.magtechjournal.com/EN/Y2015/V12/I3/182

[1]	LI Xinying, BAO Lei, LI Shuran, ZHAO Ronghua, SUN Jing, XIE Dan, BAO Yanyan, GUO Shanshan, CUI Xiaolan, GENG Zihan. Effect of Shufeng Jiedu Capsules on the Production of Specific Antibodies against Influenza A H1N1 Virus and the Mechanisms [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 841-850.
[2]	ZHAO Ronghua, ZHU Chunxu, SUN Jing, BAO Lei, WANG Xinwei, GENG Zihan, ZHANG Jingsheng, GUO Shanshan, LI Shuran, WANG Daohan, CUI Xiaolan. Mechanisms of Sanhan Huashi Granules on a Respiratory Syncytial Virus and Influenza Virus and Respiratory Syncytial Virus Induced Pneumonia Model in Mice [J]. Chinese Journal of Pharmacovigilance, 2025, 22(5): 488-494.
[3]	CHEN Qi, ZHANG Mingqiang, GUO Jun. One Case of Interstitial Pneumonia Caused by Imatinib Mesylate Tablets during the Treatment of Gastric Stromal Tumor [J]. Chinese Journal of Pharmacovigilance, 2025, 22(4): 463-465.
[4]	LIU Biqing, ZHANG Xiaotong, WANG Ke, XING Xiaoxuan, WANG Zhizhou, ZHUANG Wei, ZHANG Qingxia, ZHANG Lan, LI Xiaoling, DONG Xianzhe. Adverse Drug Reaction in 385 Elderly Inpatients with Bacterial Pneumonia under Polypharmacy [J]. Chinese Journal of Pharmacovigilance, 2025, 22(2): 206-210.
[5]	SUN Jing, ZHAO Ronghua, GUO Shanshan, GAO Shuangrong, BAO Lei, GENG Zihan, LI Shuran, SUN Qiyue, XU Zhou, QIN Guangyuan, PAN Yujie, TAN Qiuxia, LONG Zhongyi, HUANG Chenggang, CUI Xiaolan. Therapeutic effect of aerosol inhalation of BD-77 against mycoplasma pneumoniae infection in mice [J]. Chinese Journal of Pharmacovigilance, 2024, 21(3): 253-256.
[6]	HUANG Huanjun, MAI Jiaheng, ZHANG Yunhui, GUO Chenchen, LIANG Weiting. Adverse drug reaction induced by antineoplastic drugs in a cancer hospital: an analysis of 613 cases [J]. Chinese Journal of Pharmacovigilance, 2024, 21(3): 324-328.
[7]	BAO Lei, GENG Zihan, LI Shuran, JI Zuen, ZHAO Ronghua, SUN Jing, GUO Shanshan, CUI Xiaolan. The critical role of TRP channels in the progression of viral pneumonia [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 137-140.
[8]	CHEN Yuyan, ZHANG Mingxia, ZHANG Tao, ZHANG Jin. One case of interstitial pneumonia caused by serplulimab injection [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 213-215.
[9]	CAO Shan, PANG Bo, XU Yingli, ZHANG Jingsheng, CHEN Mengping, ZHANG Yu, WANG Yaxin, BAO Lei, GENG Zihan, GUO Shanshan, ZHAO Ronghua, CUI Xiaolan. Effects of Shufeng Jiedu capsules prophylactic administration on TLR4-mediated inflammatory injury in lung tissue in a mouse model of inffuenza virus infeciton [J]. Chinese Journal of Pharmacovigilance, 2024, 21(1): 45-50.
[10]	ZHANG Jingsheng, GAO Shuangrong, PANG Bo, LIU Lina, XU Yingli, CAO Shan, CHEN Mengping, ZHANG Yu, ZHAO Ronghua, CUI Xiaolan. The mechanism of Sanhan Huashi Granules on pneumonia induced by human coronavirus 229E and OC43 in mice [J]. Chinese Journal of Pharmacovigilance, 2024, 21(1): 51-54.
[11]	ZHANG Li, WANG Yujia, ZHANG Lingling, CHEN Jiaxin, LIN Minhua, LIN Xiaohui, NIE Xuekun. Surveillance data on adverse reactions associated with real-world immune checkpoint inhibitors [J]. Chinese Journal of Pharmacovigilance, 2023, 20(9): 1035-1038.
[12]	BAO Lei, GENG Zihan, GUO Shanshan, YAO Rongmei, SUN Jing, CUI Xiaolan. Effect of Reyanning Heji on animal models of respiratory infectious inflammation [J]. Chinese Journal of Pharmacovigilance, 2023, 20(3): 241-247.
[13]	ZHAO Ronghua, SUN Jing, BAO Lei, GENG Zihan, Li Guiping, WANG Daohan, LI Shuran, ZHANG Jingsheng, PANG Bo, XU Yingli, ZHOU Lirun, BAO Yanyan, CHEN Mengping, GUO Shanshan, CUI Xiaolan. Effect of Jinzhen oral liquid on the model of human coronavirus pneumonia and fever epidemic immature adult mice [J]. Chinese Journal of Pharmacovigilance, 2023, 20(3): 248-252.
[14]	ZHANG Yuan, HE Mei. Pharmaceutical care for a case of Parkinson's syndrome caused by trimetazidine hydrochloride tablets in an elderly patient with renal insufficiency [J]. Chinese Journal of Pharmacovigilance, 2023, 20(3): 343-345.
[15]	WANG Yu, HUANG Jingyi, HOU Lixin, LI Shuang, CUI Yongkang, HUANG Lanwei. Humoral immune characteristics of peripheral blood of CAP patients with antibiotic-associated DILI [J]. Chinese Journal of Pharmacovigilance, 2023, 20(2): 132-135.

Pharmaceutical Care for an Elderly Patient with Pulmonary Bacterial and Fungal Infection

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics